Ovid Therapeutics OVID
NASDAQ OVID
$2.51 -0.03 (-1.18%)
As of: Sep 30, 2026 · 3:41 PM EDT

Ovid Therapeutics (OVID) EV to EBITDA (2021)

Updated

Ovid Therapeutics' EV to EBITDA came in at 0.31 for Q4 2021, up 47.9% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) EV to EBITDA (2021) Analysis & Trends

Going back to Q1 2021, Ovid Therapeutics' EV to EBITDA data covers 4 quarters.

  • The five-year range for quarterly EV to EBITDA is 0.21 (Q3 2021) to 0.43 (Q2 2021).
  • Business Quant data shows OVID's EV to EBITDA at 0.21 (Q3 2021), 0.43 (Q2 2021) and 0.34 (Q1 2021) in the three quarters before Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Ovid Therapeutics 469.28 Mn 101.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 0.31
Sep 30, 2021 0.21
Jun 30, 2021 0.43
Mar 31, 2021 0.34
API Access

Ovid Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=OVID&period=max&api_key=YOUR_API_KEY